Position in OGN
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$3,127
+$1,744 QoQ
Shares Held
231
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#387
of 625 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NBC SECURITIES, INC. holds $34,359,930 across 16 Drug Manufacturers - General names. OGN ranks #16 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
33,355 | $8,471,169 | |
| 2 | LLY |
ELI LILLY & Co
|
5,499 | $6,595,666 | |
| 3 | MRK |
Merck & Co., Inc.
|
37,890 | $4,868,865 | |
| 4 | ABBV |
AbbVie Inc.
|
15,573 | $3,918,789 | |
| 5 | AMGN |
Amgen Inc
|
6,784 | $2,456,622 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
17,146 | $2,166,225 | |
| 7 | SNY |
Sanofi
|
32,723 | $1,395,963 | |
| 8 | GSK |
GSK plc
|
23,872 | $1,251,370 |
All Filings in OGN
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,127 | 231 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $1,383 | 231 | Shares | Sole | 2026-04-14 | |
| 2025-12-31 | $1,656 | 231 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $87,650 | 8,207 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $85,910 | 8,875 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | $132,655 | 8,909 | Shares | Sole | 2025-04-09 | |
| 2024-12-31 | $119 | 8 | Shares | Sole | 2025-01-22 | |
| 2024-09-30 | $160,711 | 8,401 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $175,329 | 8,470 | Shares | Sole | 2024-07-10 | |
| 2024-03-31 | $133,104 | 7,080 | Shares | Sole | 2024-04-05 | |
| 2023-12-31 | $101,156 | 7,015 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $129,332 | 7,450 | Shares | Sole | 2023-11-03 | |
| No filing history on record for this holder in this stock. | ||||||